Immediate Impact
92 standout
Citing Papers
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Works of Martin Goros being referenced
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Martin Goros | 165 | 71 | 248 | 75 | 9 | 432 | |
| Margit Gogg-Kamerer | 181 | 63 | 179 | 59 | 14 | 447 | |
| Michael Dudek | 164 | 44 | 275 | 75 | 11 | 445 | |
| Hisao Ezaki | 130 | 29 | 259 | 135 | 12 | 424 | |
| Michael Pimienta | 193 | 54 | 244 | 47 | 12 | 467 | |
| Natalie Thorn | 202 | 22 | 294 | 66 | 7 | 442 | |
| Jennifer Demieville | 114 | 82 | 216 | 176 | 16 | 507 | |
| Yoshiyuki Sakamaki | 168 | 64 | 285 | 115 | 5 | 472 | |
| Shamini G. Shekeran | 167 | 67 | 115 | 37 | 11 | 392 | |
| Kristin Wahl | 165 | 50 | 227 | 149 | 10 | 511 | |
| Kohji Otogawa | 125 | 45 | 179 | 148 | 8 | 390 |
All Works
Loading papers...